Trial reportBMC anesthesiology2025
Liposomal bupivacaine as an adjunct to bupivacaine-based brachial plexus block in patients undergoing rotator cuff repair: a prospective double-blind randomized controlled clinical trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liposomal Bupivacaine in Perioperative Analgesia: A Comprehensive Review of Clinical Efficacy, Safety, and Economic Context.Current pain and headache reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPatients undergoing rotator cuff repair often experience moderate to severe postoperative pain. Interscalene brachial plexus block can provide analgesia and reduce opioid requirements. Bupivacaine is a standard anesthetic used for the brachial plexus block. Whether adding liposomal bupivacaine as an adjunct to bupivacaine-based brachial plexus block could improve analgesia and postoperative functional recovery remained unclear.
methodsA prospective, double-blind, randomized controlled clinical trial was conducted in patients scheduled for rotator cuff repair between September 2024 and March 2025. Eligible patients were randomized to receive either bupivacaine alone or a combination of bupivacaine with liposomal bupivacaine. The primary outcome was postoperative recovery measured by the quality of recovery-15 (QoR-15) scale at 24, 48, and 72 h after surgery. Secondary outcomes included perioperative measurements, pain intensity, muscle strength, and post-discharge functional evaluations. Complications were recorded.
resultsA total of 113 patients (56 and 57 in the bupivacaine and combination groups, respectively) were included. Baseline characteristics were comparable between the two groups. Postoperative recovery was significantly better in the combination group than in the bupivacaine group at 48 h after surgery (P = 0.023). A greater proportion of patients in the combination group reported satisfaction than in the bupivacaine group (P = 0.023). The combination group also experienced significantly better pain relief at 12-, 24-, and 48-h but lower muscle strength between 6 and 48 h postoperatively than the bupivacaine group (all P < 0.01). Otherwise, there were no statistically significant differences between the two groups in intraoperative measurements, postoperative length of hospital stay, postoperative oxycodone consumption, heart rate, mean arterial pressure, complications, or post-discharge functional evaluations.
conclusionAdding liposomal bupivacaine to a standard bupivacaine-based brachial plexus block could safely improve postoperative recovery, pain relief, and patient satisfaction, but reduce muscle strength within 48 h after rotator cuff repair, without a significant impact on shoulder function after hospital discharge.
trial registrationRetrospectively registered, Chinese Clinical Trial Registry (registration number ChiCTR2500099378), registration date: March 21, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.